Pharmafile Logo
Pharmafocus logo
Advanced Search

Camurus

Showing 3 posts of 3 posts found.

Camurus shares phase 3 results from ACROINNOVA 2 study

July 16, 2024
Research and Development Camurus, Pharmacy, acromegaly, clinical trial, injection

Camurus has announced positive results from its 52-week phase 3 open-label ACROINNOVA 2 study, which assessed the safety and efficacy …

News
opioid_therapy_credit_-_us_air_force_valerie_monroy

Camurus’ weekly/monthly opioid dependence injection accepted in Scotland for NHS use

August 13, 2019
Manufacturing and Production, Sales and Marketing Camurus, NHS, Scotland, nhs scotland, opioid dependence, opioids, pharma

The Scottish Medicines Consortium (SMC) has announced its acceptance of Buvidal (buprenorphine prolonged-release solution for subcutaneous injection) from Swedish pharma …

News
pills-384846_960_720

Therapy able to block both opioid high and withdrawal

June 26, 2017
Manufacturing and Production, Research and Development Camurus, buprenorphine

A study into an injectable form of buprenorphine treatment for opioid abuse has found that the formulation is able to …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026